![Musk Discusses X Acquisition in Exclusive Interview [VIDEO]](/en/content/images/size/w1280/format/webp/20250731160012_tesla-humanoid-robot-optimus.jpeg)
Elon Musk Discusses Potential Takeover in Exclusive Interview - Video Footage Available
Tesla and Neuralink: A Look into Elon Musk's Innovative Vision
In a recent virtual interview at the X Takeover 2025 event, Elon Musk shared significant updates on the progress of Tesla and Neuralink projects.
Optimus Robot
The latest iteration of Tesla's humanoid robot, Optimus V3, is a significant redesign from its predecessor, V2. Almost no parts remain the same, and Musk indicated that it could be ready for volume production. If Tesla were to produce up to one billion units annually at $30,000 each, it could potentially generate around $30 trillion in revenue. The robot's intelligence is driven by the same autonomous driving computer used in Tesla cars, currently running on AI 4 hardware, with plans to upgrade to AI 5. The primary technical challenge remaining is the robot's hand design.
Tesla Semi
Beta versions of the Tesla Semi are currently undergoing durability testing, demonstrating improvements over the alpha builds. Production equipment is being installed in Tesla’s new manufacturing facility, signaling progress towards ramping up production.
New Roadster
The new Roadster remains in active development, with Tesla’s VP of Vehicle Engineering confirming preparations for a "super cool demo." Musk expressed excitement after seeing the latest internal technology previews, indicating forthcoming updates or presentations.
Neuralink Brain-Computer Interface
Neuralink's short-term goal continues to focus on addressing serious medical conditions such as paralysis and blindness. Musk also suggested that the technology might one day treat chronic illnesses like back pain, highlighting the expanding medical applications of the technology.
These insights underscore ongoing innovation across Tesla’s product lines and Neuralink’s medical ambitions, despite known regulatory and production challenges. The interview served as a reminder of Tesla's ambitious and far-reaching product roadmap.
[1] Source: Tesla Owners Silicon Valley Club interview [2] Source: Elon Musk's statement on Optimus V3 and revenue potential [4] Source: Elon Musk's suggestion of Neuralink's potential treatment of chronic conditions like back pain
- Elon Musk hinted at the potential of Neuralink's technological advancements reaching beyond its initial medical focus, possibly encompassing health-and-wellness approaches such as therapies-and-treatments for chronic conditions like back pain.
- In the realm of healthcare, Tesla and Neuralink continue to innovate, with Tesla aiming to address serious medical-conditions through its robotics division, while Neuralink sets its sights on overcoming paralysis and blindness through its brain-computer interface.
- The ever-evolving world of technology intersects with science and space-and-astronomy as Elon Musk's vision for Tesla's Optimus V3 robot draws on the same AI-powered autonomous technology found in Tesla's vehicles, potentially adapting to mitigate challenges presented by medical-conditions.
